[1] Grygiel-Górniak B, Folga BA. Chlamydia trachomatis—an emerging old entity? Microorganisms. 2023;11:1283. https://doi.org/10.3390/microorganisms11051283. [2] Sharma V, Khan MM. Current progress and future perspective of Chlamydia trachomatis infection: a rising threat to women health. Curr Microbiol. 2025;82:42. https://doi.org/10.1007/s00284-025-04287-x. [3] Passos LG, Terraciano P, Wolf N, De Oliveira FDS, De Almeida I, Passos EP. The correlation between Chlamydia trachomatis and female infertility: a systematic review. RBGO Gynecol Obstet. 2022;44:614. https://doi.org/10.1055/s-0042-1748023. [4] World Health Organization. New report flags major increase in sexually transmitted infections, amidst challenges in HIV and hepatitis. Geneva: World Health Organization; 2024. [5] Yang S, Zeng J, Yu J, Sun R, Tuo Y, Bai H. Insights into Chlamydia development and host cells response. Microorganisms. 2024;12:1302. https://doi.org/10.3390/microorganisms12071302. [6] Faris R, Merling M, Andersen SE, Dooley CA, Hackstadt T, Weber MM. Chlamydia trachomatis CT229 subverts Rab GTPase-dependent CCV trafficking pathways to promote chlamydial infection. Cell Rep. 2019;26:3380-3390.e5. https://doi.org/10.1016/j.celrep.2019.02.079. [7] Gitsels A, Sanders N, Vanrompay D. Chlamydial infection from outside to inside. Front Microbiol. 2019;10:2329. https://doi.org/10.3389/fmicb.2019.02329. [8] Wang M, Qiu X, Xu Y, et al. Impacts of penicillin G on Chlamydia trachomatis serovar D and host HeLa cells in genital infections. Arch Microbiol. 2025;207:164. https://doi.org/10.1007/s00203-025-04365-5. [9] Kozusnik T, Adams SE, Greub G. Aberrant bodies: an alternative metabolic homeostasis allowing survivability? Microorganisms. 2024;12:495. https://doi.org/10.3390/microorganisms12030495. [10] World Health Organization. Guidelines for the treatment of Chlamydia trachomatis. Geneva: World Health Organization; 2016. [11] Mestrovic T, Ljubin-Sternak S. Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs. Front Biosci (Landmark Ed). 2018;23:656-70. https://doi.org/10.2741/4611. [12] Mosolygó T, Mouwakeh A, Ali MH, Kincses A, Mohácsi-Farkas C, Kiskó G, et al. Bioactive compounds of Nigella sativa essential oil as antibacterial agents against Chlamydia trachomatis. Microorganisms. 2019;7:370. https://doi.org/10.3390/microorganisms7090370. [13] Hanski LL, Kapp K, Tiirola TM, Orav A, Vuorela HJ, Püssa T, et al. Mint flavorings from candies inhibit the infectivity of Chlamydia pneumoniae. Nat Prod Commun. 2016;11(11):1725-8. [14] Sessa R, Di Pietro M, De Santis F, Filardo S, Ragno R, Angiolella L. Effects of Mentha suaveolens essential oil on Chlamydia trachomatis. BioMed Res Int. 2015;2015:508071. https://doi.org/10.1155/2015/508071. [15] Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry. 4th ed. Carol Stream: Allured Publishing Corporation; 2009. [16] Janssen KJH, Hoebe CJPA, Dukers-Muijrers NHTM, Eppings L, Lucchesi M, Wolffs PFG. Viability-PCR shows that NAAT detects a high proportion of DNA from non-viable Chlamydia trachomatis. PLoS ONE. 2016;11:e0165920. https://doi.org/10.1371/journal.pone.0165920. [17] Lewis AJ, Richards AC, Mulvey MA. Invasion of host cells and tissues by uropathogenic bacteria. Microbiol Spectr. 2016. https://doi.org/10.1128/microbiolspec.UTI-0026-2016. [18] Agarwal P, Sebghatollahi Z, Kamal M, Dhyani A, Shrivastava A, Singh KK, et al. Citrus essential oils in aromatherapy: therapeutic effects and mechanisms. Antioxidants. 2022;11:2374. https://doi.org/10.3390/antiox11122374. [19] Dosoky NS, Setzer WN. Biological activities and safety of Citrus spp. essential oils. Int J Mol Sci. 2018;19:1966. https://doi.org/10.3390/ijms19071966. [20] Dziedziński M, Kobus-Cisowska J, Stachowiak B. Pinus species as prospective reserves of bioactive compounds with potential use in functional food—current state of knowledge. Plants. 2021;10:1306. https://doi.org/10.3390/plants10071306. [21] Jurado P, Uruén C, Martínez S, Lain E, Sánchez S, Rezusta A, et al. Essential oils of Pinus sylvestris, Citrus limon and Origanum vulgare exhibit high bactericidal and anti-biofilm activities against Neisseria gonorrhoeae and Streptococcus suis. Biomed Pharmacother. 2023;168:115703. https://doi.org/10.1016/j.biopha.2023.115703. [22] Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS. 2003;14:109-13. https://doi.org/10.1258/095646203321156872. [23] Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: a multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45:e13566. https://doi.org/10.1111/jfbc.13566. [24] Gupta A, Jeyakumar E, Lawrence R. Strategic approach of multifaceted antibacterial mechanism of limonene traced in Escherichia coli. Sci Rep. 2021;11:13816. https://doi.org/10.1038/s41598-021-92843-3. [25] Cossé MM, Hayward RD, Subtil A. One face of Chlamydia trachomatis: the infectious elementary body. Curr Top Microbiol Immunol. 2018;412:35-58. https://doi.org/10.1007/82_2016_12. [26] Degn LLT, Bech D, Christiansen G, Birkelund S. Lack of neutralization of Chlamydia trachomatis infection by high avidity monoclonal antibodies to surface-exposed major outer membrane protein variable domain IV. Mol Immunol. 2023;163:163-73. https://doi.org/10.1016/j.molimm.2023.09.015. [27] Gitsels A, Van Lent S, Sanders N, Vanrompay D. Chlamydia: what is on the outside does matter. Crit Rev Microbiol. 2020;46:100-19. https://doi.org/10.1080/1040841X.2020.1730300. [28] Strange N, Luu L, Ong V, Wee BA, Phillips MJA, McCaughey L, et al. HtrA, fatty acids, and membrane protein interplay in Chlamydia trachomatis to impact stress response and trigger early cellular exit. J Bacteriol. 2024;206:e00371-23. https://doi.org/10.1128/jb.00371-23. [29] Mukhtar YM, Adu-Frimpong M, Xu X, Yu J. Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs. Biosci Rep. 2018;38:BSR20181253. https://doi.org/10.1042/BSR20181253. [30] Jung D, Bachmann HS. Regulation of protein prenylation. Biomed Pharmacother. 2023;164:114915. https://doi.org/10.1016/J.BIOPHA.2023.114915. [31] Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, et al. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation. 2003;108:261-5. https://doi.org/10.1161/01.CIR.0000083367.93022.78. [32] Hardcastle IR, Rowlands MG, Moreno Barber A, Grimshaw RM, Mohan MK, Nutley BP, et al. Inhibition of protein prenylation by metabolites of limonene. Biochem Pharmacol. 1999;57:801-9. https://doi.org/10.1016/S0006-2952(98)00349-9. [33] Maier AG, Matuschewski K, Zhang M, Rug M. Plasmodium falciparum. Trends Parasitol. 2019;35:481-2. https://doi.org/10.1016/j.pt.2018.11.010. [34] Moura IC, Wunderlich G, Uhrig ML, Couto AS, Peres VJ, Katzin AM, et al. Limonene arrests parasite development and inhibits isoprenylation of proteins in Plasmodium falciparum. Antimicrob Agents Chemother. 2001;45:2553-8. https://doi.org/10.1128/AAC.45.9.2553-2558.2001. [35] Crowell PL, Ren Z, Lin S, Vedejs E, Gould MN. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol. 1994;47:1405-15. https://doi.org/10.1016/0006-2952(94)90341-7. [36] Crowell PL, Chang R, Ren Z, Elson CE, Gould MN. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem. 1991;266:17679-85. [37] Duelund L, Amiot A, Fillon A, Mouritsen OG. Influence of the active compounds of Perilla frutescens leaves on lipid membranes. J Nat Prod. 2012;75:160-6. https://doi.org/10.1021/np200713q. [38] Rolim TS, Sampaio ALF, Mazzei JL, Moreira DL, Siani AC. Synthesis, bioproduction and bioactivity of perillic acid: a review. Molecules. 2025;30:528. https://doi.org/10.3390/molecules30030528. |